Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-013397
Filing Date
2023-09-19
Accepted
2023-09-19 16:09:57
Documents
1
Period of Report
2023-09-19

Document Format Files

Seq Description Document Type Size
1 form4-09192023_080951.html 4  
1 form4-09192023_080951.xml 4 7717
  Complete submission text file 0001415889-23-013397.txt   9248
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121
Business Address
LaBarre Michael J. (Reporting) CIK: 0001507174 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 231263805